INNOCARE(09969.HK): 2026 Nine-Month Report - Profit Attributable to Shareholders stood at CNY 655.7 million, turned profitable from a loss YoY

NewTimeSpace News: October 26, 2026, INNOCARE(09969.HK) released its Nine-Month Report for the period ended December 31, 2026, Total Revenue stood at CNY 2.1 billion, increased by 88.21% YoY; Net Profit stood at CNY 648.35 million, turned profitable from a loss YoY; Profit Attributable to Shareholders stood at CNY 655.7 million, turned profitable from a loss YoY; Basic Earnings Per Share (EPS) stood at CNY 0.39.
In terms of profitability, INNOCARE Gross Profit changed from CNY 990.15 million in the same period last year to CNY 1.91 billion in the current period, increased by CNY 923.98 million; gross profit margin changed from 88.78% in the same period last year to 91.19% in the current period, increased by 2.41 percentage points; net profit changed from loss of CNY 71.95 million in the same period last year to CNY 648.35 million in the current period, increased by CNY 720.3 million; net profit margin changed from -6.45% in the same period last year to 30.89% in the current period, increased by 37.34 percentage points.
In terms of earnings quality, INNOCARE Operating Profit changed from loss of CNY 64.69 million in the same period last year to CNY 659.47 million in the current period, increased by CNY 724.16 million; Operating Profit Margin changed from -5.8% in the same period last year to 31.42% in the current period, increased by 37.22 percentage points; Net Cash Flow from Operating Activities changed from cash outflow of CNY 84.34 million in the same period last year to cash inflow of CNY 219.61 million in the current period, increased by CNY 303.95 million; Ratio of Net Cash Flow from Operating Activities to Total Operating Revenue changed from -7.56% in the same period last year to 10.46% in the current period, increased by 18.02 percentage points.
In terms of financial soundness, INNOCARE Debt-to-Asset Ratio changed from 29.88% in the same period last year to 28.51% in the current period, decreased by 1.37 percentage points; Total Equity changed from CNY 6.678 billion in the same period last year to CNY 8.204 billion in the current period, increased by CNY 1.53 billion; Cash and Cash Equivalents changed from CNY 4.382 billion in the same period last year to CNY 3.698 billion in the current period, decreased by CNY 683.96 million; Current Liabilities changed from CNY 1.22 billion in the same period last year to CNY 2.18 billion in the current period, increased by CNY 957.32 million; Quick Ratio changed from 6.44 in the same period last year to 4.06 in the current period, decreased by 2.38 percentage points.
In terms of R&D investment focus, INNOCARE R&D Expenses changed from CNY 676.05 million in the same period last year to CNY 785.05 million in the current period, increased by CNY 109.01 million; R&D to Total Revenue Ratio changed from 60.61% in the same period last year to 37.4% in the current period, decreased by 23.21 percentage points.
By the close of trading on October 26, 2026, INNOCARE(09969) saw a loss of 1.36% in its share price, closing at HKD 11.61. The full-day turnover stood at HKD 80.95 million, with the latest market capitalization at HKD 17.34 billion.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.